Hepatites
Estudo de coorte | Entre pacientes com hepatite B resolvida e doenças autoimunes concomitantes, a exposição a doses de prednisona maiores que 20 mg/dia foi associada com alto risco para reativação do vírus da hepatite B (VHB) ou surto de hepatite.
21 Jan, 2022 | 15:39hAverage corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection – Annals of Rheumatic Disease (link para o resumo – $ para o texto completo)
Comentário no Twitter
Patients with time-weighted average prednisone dose greater than 20 mg/day would be classified as the high risk for HBV reactivation or hepatitis flare. Prophylactic Anti-HBV therapy may be needed for these high-risk patientshttps://t.co/qLuirdyXDK pic.twitter.com/yDJ4c072qm
— ARD & RMD Open (@ARD_BMJ) December 23, 2021
OMS insiste para que os países aumentem os serviços para tratamento de hepatites.
3 Ago, 2021 | 11:19hWHO Urges Countries to Increase Hepatitis Services – Health Policy Watch
Campanha OMS: World Hepatitis Day (28 de julho)
Novas diretrizes OMS:
Recommendations and guidance on hepatitis C virus self-testing – World Health Organization
Interim guidance for country validation of viral hepatitis elimination – World Health Organization
OMS lança a primeira diretriz global para validação dos países sobre eliminação das hepatites virais B e C.
15 Jul, 2021 | 10:33hComunicado de imprensa: WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination – World Health Organization
Ver diretriz: Interim guidance for country validation of viral hepatitis elimination – World Health Organization
Novo relatório da OMS destaca o progresso global na redução de HIV, hepatite viral e infecções sexualmente transmissíveis e sinaliza a necessidade de se renovar os esforços para atingir as metas de 2030.
21 Mai, 2021 | 10:10hComunicado de imprensa: New report highlights global progress on reducing HIV, viral hepatitis and sexually transmitted infections and signals need for renewed efforts to reach 2030 targets
Relatório original: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
Every year HIV, viral hepatitis, and sexually transmitted infections account for 2.3M deaths, and 1.2M cancers
🆕WHO report highlights achievements, gaps, and actions towards eliminating these diseases as public health threats by 2030 👉https://t.co/8kcVqZe0Yj pic.twitter.com/U07hKRumVt
— World Health Organization (WHO) (@WHO) May 20, 2021